Merck's Hyzaar Adds Front-Line Severe Hypertension Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
The antihypertensive was previously indicated for initial use only when hypertension was severe enough that the value of promptly controlling blood pressure exceeded the risk of therapy with the losartan/hydrochlorothiazide combination.